Design Against Ageism
Original HTML

There’s a lot of talk about “the magic of technology.” As a society, we’ve centralized ourselves around the concept of tech wonderment, but we’ve lost our sense of wonder about aging. This is an important challenge that we are facing around ageism. It’s a question of how older people are viewed and brings up the need for social change to build a healthy ecosystem for older adults to learn and use technology.

Class (B2B/B2C)
Ignore
Ingest Status
Rejected
Dedupe hash
087c8486c8b272d2ec75b1ef25467e93
Press Eligible
No
Press Eligible Reason
Text too short (76 words. Min: 150)
Source Name
Older Adults Technology Services (OATS) from AARP
Content Hash (SHA-256, erste 32 hex)
9c5d15bdaf01886e9408a0ea74065cd1
Environmental, Social and Governance Policy
Image File
Original HTML

Introduction and Purpose

KMS Lighthouse is dedicated to exceeding environmental responsibilities beyond mere compliance with laws and regulations. Our commitment is to reduce the environmental impact of our operations and ensure a safe, healthy workplace for our employees. We aim to integrate best practices into all aspects of our business.

Our goals at KMS Lighthouse include:

- Integrating environmental considerations into our decision-making processes.

- Reducing waste through recycling and reusing materials wherever possible.

- Continuously improving our environmental performance.

- Communicating our environmental goals and achievements to stakeholders.

- Ensuring compliance with all relevant environmental regulations.

- Regularly reviewing and enhancing our sustainability efforts.

Scope

This Policy aims to:

- Identify and mitigate the environmental impacts of our operations.

- Comply with environmental regulations in all regions where we operate.

- Promote efficient use of energy and water through conservation initiatives.

- Implement waste reduction strategies, focusing on recycling and reusing materials.

- Raise environmental awareness among employees through education and engagement.

- Collaborate with stakeholders to address environmental priorities.

- Minimize our carbon footprint by encouraging virtual meetings.

- Develop sustainable procurement practices across our supply chain.

This Policy applies to all KMS Lighthouse offices, employees, and associated partners, including suppliers, vendors, service providers, contractors, and consultants.

Our Commitment

We foster environmental awareness among our employees, encouraging them to support our sustainability goals through their daily actions. Initiatives include:

Travel and Transport

- Prioritizing public transportation and informing employees about commuter benefits.

- Encouraging virtual meetings to minimize business travel.

- Planning and scheduling to reduce the frequency of flights.

- Supporting carpooling and group travel for business trips.

Office Green Initiatives

- Providing recycling bins for easy disposal of recyclables.

- Encouraging the use of reusable mugs, dishes, and cutlery.

- Using coffee makers that do not require paper filters and composting coffee grounds.

- Maintaining live plants in our offices.

- Using environmentally friendly cleaning products.

- Promoting paperless practices and responsible printing.

- Ensuring lights and air conditioning units are turned off after office hours.

Sustainable Sourcing

We aim to purchase environmentally friendly products and services, such as:

- Recycled content products to reduce landfill waste.

- Energy-efficient products to lower electricity consumption.

- Green cleaning products certified by third-party organizations.

- Water or vegetable-based inks to reduce VOC emissions.

- Supporting local businesses in our procurement processes.

Waste Reduction

We strive to minimize natural resource consumption and manage waste responsibly:

- Replacing disposable items with durable, reusable alternatives.

- Ensuring IT equipment is reconditioned or disposed of sustainably.

- Phasing out single-use plastics and providing reusable alternatives.

- Complying with regulations for disposing of electrical items.

Paper and Water Use

- Reducing paper use and purchasing recycled paper.

- Reusing and recycling paper.

- Implementing water conservation measures, especially in water-stressed regions.

Energy Usage and Carbon Emissions

We are committed to reducing our carbon footprint through:

- Using clean, carbon-free electricity sources.

- Replacing fluorescent lights with energy-efficient LEDs.

- Evaluating equipment for energy efficiency.

- Performing regular maintenance on HVAC systems.

External Compliance

We expect our partners to operate responsibly and comply with environmental laws and standards.

Governance, Implementation, and Reporting

KMS Lighthouse has a governance system to implement and review this Policy annually. The Policy is reviewed by our company executives.

We train employees on ESG risks and opportunities and engage with stakeholders to incorporate diverse perspectives. We share information on our sustainability initiatives and encourage employee involvement.

Policy Revision

This Policy will be reviewed regularly to ensure its relevance and adequacy, with amendments made as necessary.

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
a9ac5e5bda7596535a6c4b8bb5b76287
Press Eligible
Yes
Press Eligible Reason
Company ESG and sustainability policy for employees, suppliers, and stakeholders.
Source Name
KMS Lighthouse
Image URL
https://kmslh.com/wp-content/uploads/2020/04/Screenshot-12.png
Source Node
Content Hash (SHA-256, erste 32 hex)
60ba7994f89a016b0d25d37bc1ed34f5
Natively Integrates With Your Favorite Applications
Image File
Original HTML

We partnered with the best, so you can manage your knowledge with the tools you love.

Elevate your knowledge management to new heights with our Azure OpenAI integration

Integrating Azure OpenAI’s enhanced AI features into KMS Lighthouse’s system provides an efficient, personalized, and comprehensive customer experience. Improve the authoring experience by generating auto-responses or suggesting relevant articles, resources, or solutions – empowering customers to find answers to their questions or resolve issues on their own.

Empower your Salesforce journey with KMS Lighthouse’s knowledge synergy

Enhance your Salesforce experience by seamlessly integrating KMS Lighthouse. Elevate your team’s productivity with instant access to critical knowledge within the Salesforce platform. 

Effortlessly bridge the gap between customer relationship management and knowledge management, ensuring a smoother workflow and better-informed decisions.

Supercharge your customer engagement strategy by integrating KMS Lighthouse with Genesys. Elevate agent performance with quick access to relevant knowledge during customer interactions.

Efficiently resolve queries, provide accurate information, and deliver a superior customer experience by integrating knowledge seamlessly into the Genesys platform.

Integrating KMS Lighthouse with Zendesk brings seamless knowledge management capabilities to the customer support experience. With KMS Lighthouse, critical knowledge is easily shared without having to leave the Zendesk platform. Quickly address key knowledge gaps while delivering more efficient and effective customer support.

Supercharge your knowledge management with our AWS integration

Integrating AWS’s powerful cloud services into KMS Lighthouse’s system ensures a robust, scalable, and secure customer experience. Enhance your operational efficiency with seamless data storage, high-performance computing, and advanced analytics capabilities – empowering your team to deliver quick and reliable solutions while enabling customers to access the information they need effortlessly.

Tell us about the integration you’re interested in, and we’ll see what we can do.

Class (B2B/B2C)
B2B
Ingest Status
Error
Dedupe hash
21cbf8c2655619630f188bcf98b60b86
Press Eligible
No
Press Eligible Reason
Drupal Push 422
Source Name
KMS Lighthouse
Image URL
https://kmslh.com/wp-content/uploads/2023/12/Frame-375.png
Source Node
Content Hash (SHA-256, erste 32 hex)
7eb2667532a2d182e53ef2e21fd094a6
ICHRA Compliance and Enrollment: Why “ICHRA Plans” Don’t Exist
Original HTML

April 2026 | By Lindsey Miller

Key takeaways for health plans:

- Brokers and vendors directly impact ICHRA compliance, conversion, and long-term retention.

- ICHRA enrollment is driven by behavior, not new products.

- Plans that align plan design, pricing, and networks to member preferences will outperform those leading with lowest-cost options.

Let’s clear something up: there is no such thing as an “ICHRA plan.”

Individual Coverage Health Reimbursement Accounts (ICHRAs) are not a new line of business or a special product sitting next to Bronze, Silver, or Gold. ICHRA members enroll in the same Individual market plans as everyone else. What’s changed is how people come into the experience and what they expect it to feel like.

For brokers, this is where a lot of conversations start to drift. Employers ask what “ICHRA plans” they should be offering. Health plans ask how to position their “ICHRA products.” But nothing new has been added to the shelf. The same plans are there. What’s changed is who is shopping, and how they make decisions.

Why ICHRA Growth Is Reshaping Member Expectations

Most ICHRA enrollments aren’t coming from traditional Individual-Market consumers – They’re coming from employer-sponsored group coverage. That shapes expectations. Enrollees demand:

- Predictable copays

- Familiar provider networks

- A sense of “group-like” stability

When health plans treat ICHRA as just Individual enrollment, they miss this behavioral shift.

You can see it almost immediately when someone starts shopping. A member who has been on a group plan for years doesn’t approach the experience like a typical individual-market shopper. They’re not starting from scratch. They’re comparing everything to what they had before.

That’s where a lot of friction comes in. Someone used to copays is suddenly looking at a high deductible. Someone who has always had broad access is now being asked to think about network tiering. Even when the pricing makes sense, it doesn’t always feel right to the member.

This is where brokers end up spending the most time. Not just walking through options, but translating the differences and helping people relearn what “good coverage” looks like in a new model.

ICHRA is starting to feel a lot like a 401(k). The employer sets the contribution, and the employee is responsible for choosing how to use it. That shift sounds simple, but it puts a lot more pressure on the decision-making moment.

In a 401(k), people rely on tools, guidance, and advisors to make confident choices. ICHRA is no different. If anything, the stakes feel higher because it is tied to access to care.

Health plans have a role to play here. Not just in the plans they offer, but in how they support the broker channel. Brokers are the ones guiding these decisions. They are not optional in the process.

That means investing in broker tools. Shopping experiences that make plan differences clear. Side-by-side comparisons. Workflows that allow brokers to stay involved throughout the process and maintain their broker of record status.

When that support is there, the experience feels guided. When it is not, brokers are left filling the gaps manually, and that is where decisions slow down or fall apart.

Building a Plan Portfolio That Supports ICHRA Enrollment

The ICHRA population is mixed by design.

Within a single employer contribution structure, you may have a 26-year-old single employee, a family with young children, and a 60-year-old nearing Medicare eligibility all shopping with the same defined contribution.

That reality plays out in very different ways during enrollment. Some employees are comfortable optimizing for premium and taking on more risk. Others are looking for something that feels as close as possible to their previous group plan, even if it costs more.

If a health plan’s strategy is “lead with the lowest premium Bronze plan,” they risk losing share — and margin — because that approach ignores traditional and “safe” group preferences.

Narrow network, high-deductible plans tend to attract younger, more price-sensitive members. Copay-driven Silver designs resonate more with those coming from traditional group coverage. And in some cases, employers are deliberately setting contributions at a level that encourages enrollment into richer Gold plans because they want more predictability for their employees.

From a broker perspective, this is where placement gets won or lost. It is not about having one “best” plan. It is about having a portfolio that actually maps to how different employees think about coverage.

One size fits all isn’t efficient. It’s a growth limiter.

ICHRA Compliance and Strategy: Why It’s a Funding Model, Not a Product

Successful carriers understand this distinction. They don’t build an “ICHRA plan.” They build an Individual market portfolio that mirrors group expectations.

That means:

- Plan designs that feel familiar to former group members

- Network configurations aligned to employer geographies

- Pricing strategies that anticipate defined contribution dynamics

The mistake is reacting too quickly and trying to engineer an “ICHRA-friendly” portfolio from scratch. The smarter approach is to start where you already have strength in the group market. Look at the plans members are choosing. And watch how those preferences translate when those same populations move into ICHRA.

SureCo cited that 86% of ICHRA-funded members changed plans year over year, but 72% stayed with the same carrier. Year one is often about getting something in place; year two is where people start making more informed decisions once they understand how the market works.

That has real implications for how health plans think about 2027 and beyond. Instead of trying to predict the perfect portfolio upfront, there is an opportunity to learn from selection behavior. Which plans are people moving into after their first year? Where are they trading up for richer benefits? Where are they pulling back on premium?

Members should not feel like they are starting over. They should feel like they are choosing between options that resemble what they already understand, just within a different funding structure.

Winning ICHRA Growth: What Brokers and Carriers Need from ICHRA Vendors

As ICHRA adoption grows, the winners won’t be the carriers with the cheapest plan.

They’ll be the health plans who:

- Understand enrollment behavior shifts

- Track selection patterns in real time

- Adjust plan mix to protect margin while expanding share

Brokers see this play out very clearly. Some carriers are consistently easier to place business with because their portfolio “fits” the population. Others create friction, even if the pricing is competitive, because the plans do not align with what employees are expecting.

ICHRA growth means offering the right mix of familiar options within a new funding model.

If you want to keep up with how this is evolving, you can connect with me on LinkedIn. I’m always sharing ICHRA hot takes and posting about upcoming speaking engagements.

Drop me a line if you’re as excited about where this is going as I am.

Class (B2B/B2C)
B2B
Ingest Status
Error
Dedupe hash
07505542659683d88717b56784c64c8a
Press Eligible
No
Press Eligible Reason
Drupal Push 422
Source Name
Softheon
Image URL
https://softheon.com/wp-content/uploads/2026/04/AdobeStock_237330799-scaled.jpeg
Source Node
Content Hash (SHA-256, erste 32 hex)
a2b5c01c2e474f116c91f8c28021e4df
Purpose-Built for 
the ACA Marketplace. Proven 
from Day One
Original HTML

Purpose-Built for the ACA Marketplace. Proven from Day One

Serving millions of Marketplace members since 2014, Softheon helps health plans launch, scale, and operate ACA lines of business in compliance and with confidence.

The ACA marketplace is constantly evolving. Your technology should evolve faster.

Rated 2026 “Best in KLAS” – See the Report

More than a Decade of ACA Enrollments - and We’re Just Getting Started

Our ACA marketplace software automates enrollment, billing, and compliance while unlocking better member engagement and operational efficiency. From initial eligibility through effectuation, retention, and reporting, we make it easier to support every member, every time.

Better Outcomes for You and Your Members

Update technology to meet changing regulations

Make healthcare more accessible

Automate manual tasks to free up teams

1 in 3 ACA Marketplace Plans Trust Softheon

One third of all Marketplace plans choose Softheon as their all-in-one ACA Marketplace technology partner

“Softheon’s expert knowledge of the ACA marketplace coupled with their leading enrollment and billing technology has made them the perfect partner during Hometown Health’s first open enrollment period on the exchange.”

David Hansen | CEO, Hometown Health

“[Softheon has] a fantastic solution and its performance has been great… the strength of the vendor relationship isn’t whether you have problems or not, it’s how you go about solving them and those issues.”

Paul Wingle | WellSense

“Anyone in group coverage knows the prices are rising. And they are rising astronomically. Small employers are cutting it off and deciding to not offer more and more every year… With ICHRA, we now have an opportunity to use our Marketplace plans and, through ICHRA administration with Softheon, offer smaller employers a more affordable healthcare option.”

Daverick Isaac | Community First Health Plans

All-in-One Systems and Support for ACA Marketplace & Enrollment

Replace fragmented legacy tools with a unified platform built for the Individual market.

Softheon delivers everything health plans need to manage On and Off-Exchange operations in one secure, integrated platform. We automate complex workflows, streamline compliance tasks, and give teams real-time control over their operations.

Simplified eligibility and enrollment

Frictionless payments and billing

Streamlined reporting and compliance

Flexible infrastructure that’s built to scale

Want a "Gut Check" Before OE?

Get a free OE readiness consultation with Softheon’s experts to discuss your biggest operational sticking points and practical changes that can help your team and members this enrollment season.

Not Only Do We Support the ACA - We Helped Shape It

- 1998 Before Softheon existed, founder Eugene Sayan filed a patent 6,477,569 B1 titled Method and Apparatus for Computer Network Management. This innovation laid the foundation for what is now known as agentic process automation, envisioning software agents that could intelligently route and optimize complex workflows. That bold idea became the DNA of Softheon: A culture of innovation, continuous improvement, and a commitment to building adaptive systems that make healthcare simpler, smarter, and more member-centric.

- 2000 Softheon launched with a vision to simplify complexity through technology. The company quickly built credibility with enterprise clients like Sony, JCPenney, and Chase by delivering powerful workflow and content management systems. Those early projects honed the team’s skills in large-scale integration and process automation. They set the stage for Softheon’s eventual pivot to healthcare, where the need for transformation was even greater.

- 2006 When Massachusetts created the first state health exchange, Softheon worked with Perot Systems to deliver an enrollment, billing, and CRM solution in just 90 days, helping launch Romneycare successfully. This achievement became the blueprint for the ACA Marketplaces that followed. It proved Softheon could build and operate exchange infrastructure at scale, balancing speed, compliance, and member experience.

- 2012 Softheon expanded into private health exchanges, giving employers, brokers, and individuals new ways to shop for and manage coverage. These platforms helped drive consumer-driven healthcare long before it became mainstream. The lessons learned from private exchanges shaped Softheon’s later work in the Marketplace. The technology stack was refined to handle complex enrollment, billing, and reconciliation processes in both public and commercial environments.

- 2020 Softheon launched subsidiary W3LL, an integration engine connecting brokers, benefit partners, and ICHRA administrators directly to leading health plans. Bringing seamless On-Exchange enrollments, automated payments, and Off-Exchange ICHRA growth under one roof. Visit W3LL.com to learn more.

- June 2022 Softheon partnered with Cox HealthPlans, a provider-aligned organization in Missouri, to power its Medicare Advantage operations. Bringing the same trusted technology already used on the ACA Marketplace, Softheon modernized Cox’s enrollment, billing, and compliance capabilities to keep pace with market growth. We are proud to support health plans across lines of business, lowering administrative costs for organizations focused on community-driven care.

- Sep 2022 Softheon acquired NextHealth Technologies alongside its AI-powered analytics platform, bringing advanced data-science capabilities into the Softheon ecosystem. The technology and talent from this acquisition strengthened Softheon’s ability to help health plans reduce administrative costs, improve effectuation and retention rates, and personalize member engagement. Founder and CEO Eugene Sayan shared, “Artificial intelligence in healthcare is here, and we are seeing the incredible impact it can have on both members and carriers. Our goal has been to make healthcare more affordable, accessible, and plentiful, and we see AI as a clear path forward to bring efficiencies to our carrier partners. This acquisition is a testament to Softheon’s commitment to helping health plans tackle some of their biggest challenges, such as population health and the movement toward consumerism in healthcare.”

- 2024 Softheon launched CITIZ3N, a subsidiary with a purpose-built platform to help state and federal agencies modernize eligibility, enrollment, and verification processes. CITIZ3N combines Softheon’s two decades of Marketplace expertise with advanced automation, identity verification, and secure data exchange. CITIZ3N's Verify platform helps agencies streamline eligibility decisions, reduce fraud, waste, and abuse, strengthen program integrity, and allows for community engagement and work requirement tracking. With CITIZ3N, Softheon expanded its mission beyond carriers to help governments deliver benefits more efficiently and equitably. Visit Citiz3n.com to learn more.

- Today Softheon powers shopping, enrollment, billing, payments, and analytics for millions of Americans across ACA, Medicare Advantage, and ICHRA. Health plans rely on our technology to reduce administrative burden, improve member experience, and scale new coverage models. Our focus remains on simplifying healthcare operations and expanding access to affordable, high-quality coverage for every member we serve. As a preferred partner for ACAP, ACHP, and Health Plan Alliance, we believe that it takes the entire industry working together to make healthcare more affordable, accessible, and plentiful for every American.

Insights to Move You Forward

Going from Over 10K to Nearly 1M Members

Third-Party Payment Program Generates Annualized 2.2X ROI

ACA Marketplace and Enrollment FAQs

Marketplace

How is member data protected across the platform?

Softheon architected its solution for healthcare from the ground up, delivering security controls baked in — not added later. We support HIPAA, SOC 1 Type 2, SOC 2 Type 2, PCI DSS, NIST 800-53, FIPS 140-2, and MARS-E compliance.

Every transaction, interface, and stored dataset is encrypted, audited, and logged. Role-based access, separation of duties, and continuous monitoring ensure health plans meet the highest standards of privacy and trust.

AI Enhancements

How can health plans future-proof their operations against policy change?

Softheon’s configurable rules engine lets plans adjust eligibility, billing, and notice logic without major rebuilds. This flexibility keeps plans compliant through Marketplace, Medicare, and ICHRA rule changes.

Having adaptable infrastructure helps national and community plans stay stable in shifting regulatory environments.

AI Enhancements

How do integrated systems reduce administrative costs for health plans?

Integration eliminates duplicate data entry, manual reconciliations, and system silos. By linking enrollment, billing, and eligibility in one place, Softheon automates tasks that would otherwise require multiple vendors or FTEs.

This drives measurable cost reductions and lets operations teams focus on improving member experience.

Marketplace

How can health plans streamline Marketplace operations?

Health plans can combine shopping, enrollment, billing, and compliance workflows into one integrated platform to minimize friction and errors. Softheon’s all-in-one ACA Marketplace Cloud improves effectuation rates, simplifies premium payments, and provides the insights needed to retain members.

By automating reconciliation with CMS and exchanges, plans can validate enrollments faster and resolve discrepancies in real time. Downstream systems always reflect accurate member and subsidy data without manual syncing.

Marketplace

What helps plans manage changes during Open Enrollment and policy shifts?

Plans need flexible systems that can adapt to new rules, notices, and eligibility updates that often arrive late in the cycle.

Class (B2B/B2C)
B2B
Ingest Status
Error
Dedupe hash
5312f3ed835fbb05cd04b350c24b14ea
Press Eligible
No
Press Eligible Reason
Drupal Push 422
Source Name
Softheon
Image URL
https://softheon.com/wp-content/uploads/2025/10/marketplace_hero_img.png
Source Node
Content Hash (SHA-256, erste 32 hex)
30633cffc619083c13c97c6324b7b8f4
Foods to Avoid If You Are Taking Ozempic or Wegovy for Weight Loss
Image File
Original HTML

Weight loss with Ozempic or Wegovy often means avoiding certain foods to minimize side effects from the medications.

At the same time, it's important to prioritize some foods to stay healthy and continue weight loss success.

Both drugs contain semaglutide, a synthetic version of a hormone known as GLP-1, which the body releases into the intestine when people eat food, reducing feelings of hunger.

But in addition to losing weight, people taking GLP-1 medications "lose a ton of muscle," so it's important to get enough protein, said NBC News medical contributor Dr. Natalie Azar on TODAY in a segment that aired in July 2025.

"GLP-1 therapies are powerful, but they’re most effective when paired with intentional, nutrient-dense eating patterns," said Dr. Lydia Alexander, immediate past president of the Obesity Medicine Association, in a statement.

"Nutrition is not an afterthought — it’s a therapeutic partner."

Eating right helps patients sustain weight loss and preserve lean mass, she added.

Alexander is co-author of an advisory listing nutritional strategies for GLP-1 patients, published in four journals in May 2025.

GLP-1s “can present challenges” such as gastrointestinal side effects, risk of nutrient deficiencies, and muscle and bone loss, but nutrition therapy can help, said Dr. Dariush Mozaffarian, the paper's lead author and professor at the Tufts School of Medicine.

Ozempic is a Type 2 diabetes treatment sometimes prescribed off-label for weight loss. Wegovy is the form of Ozempic specifically approved to treat obesity.

Their most common side effects include nausea, diarrhea, vomiting, stomach pain and constipation, according to Novo Nordisk, the pharmaceutical company that makes both medications.

What to Eat on Ozempic

Experts offer this advice:

Eat Smaller and More Frequent Meals

Vomiting is more likely with big meals, so eat a small breakfast and then additional small meals every three to four hours while drinking adequate fluids. Ginger or peppermint tea can be beneficial for avoiding nausea.

It's possible to feel a bit more sluggish since people on GLP-1s are eating less, so having smaller, more frequent nutrient-dense meals can help that, Azar said.

Healthy smoothies and protein drinks with fruits, vegetables and unsweetened milks or yogurt; cottage cheese and soups can provide needed nutrients when appetite is low.

Restaurants are even creating "Ozempic menus" that feature mini meals with bite size portions for diners who take GLP-1 drugs and have a reduced appetite.

Gradually Increase Fiber

Constipation is common with weight loss, so GLP-1 patients should eat foods with higher water content, including fruits and vegetables, which keep things moving in the digestive system. Examples include watermelon, cucumber, strawberries and tomatoes.

They should also gradually increase foods with soluble and insoluble fiber, such as prunes or other dried fruits.

Eat Nutrient-Dense, Minimally Processed Foods

The list includes fruits, vegetables, whole grains, legumes, lean proteins, nuts and seeds.

Consider Supplements

Dietary supplements may be needed to supply "at-risk nutrients" such as vitamin D, calcium or B12.

Prioritize Protein-Rich Foods

Since GLP-1 drugs reduce appetite, patients may not be getting enough protein, which is important to preserve muscle mass.

Aim to get 20 to 30 grams of protein per meal every day, Azar advised.

Eat lots of nutrient-dense, high-protein foods such as fish, eggs, Greek yogurt, cottage cheese, nuts and seeds. It may be helpful to supplement with high-protein shakes and bars.

Plant sources of protein include beans, peas, lentils and whole grains.

Eat the protein portion of your meal first to boost the chances of getting enough. Supplement with a protein shake if you have a decreased appetite, Azar noted.

Minimize red and processed meat since it's linked with heart disease and colorectal cancer.

Get Enough Liquids

People on GLP-1s can get really dehydrated, so they should aim for eight to 12 cups of water every day, Azar said.

“I have seen patients with chronic nausea and vomiting on (semaglutide), which can cause dehydration and malnutrition if you can’t get enough calories or fluids daily,” registered dietitian Emily Rubin, director of clinical dietetics in the division of gastroenterology and hepatology at Thomas Jefferson University Hospital in Philadelphia, previously told TODAY.com.

Make sure you're staying hydrated, even if you're not hungry, said Dr. Maria Daniela Hurtado Andrade, an endocrinologist at the Mayo Clinic’s Precision Medicine for Obesity program. She's a consultant for Novo Nordisk.

Be a Mindful Eater

Mindful eating is key to success for patients taking these drugs, Hurtado Andrade added.

Stop when you're feeling full. Commit to eating healthier food as semaglutide reduces hunger and cravings for unhealthy options, Dr. Zhaoping Li, professor of medicine and chief of the division of clinical nutrition at the University of California, Los Angeles, previously told TODAY.com.

The drug provides a "window of opportunity" to adopt a nutritious diet, she said.

“You can have the chance to make the right decisions — to eat good food,” Li said.

What Foods Can Make You Sick on Ozempic?

Patients should avoid foods that may worsen gastrointestinal symptoms such as high-fat and spicy dishes, researchers wrote in the journal Obesity.

GLP-1 medications also slow stomach emptying, which can lead to uncomfortable symptoms, doctors say.

“Food remains in the stomach for a longer period of time. This is one mechanism that contributes to weight loss with this class of medications — people using them have a prolonged sense of satiety and greater portion control,” Dr. Christopher McGowan, an obesity medicine physician and founder of True You Weight Loss in Cary, North Carolina, tells TODAY.com.

“(But) this is exactly why many patients experience nausea and even vomiting with the GLP-1 medications.”

Some foods may stay in the stomach for many hours or even days when taking these drugs, he notes.

Here are foods to avoid on Ozempic and other weight loss medications:

Greasy, High-Fat Foods

They are slower to digest and tend to stay in the stomach the longest, McGowan says.

The longer food remains in the stomach, the more likely a person is to experience nausea and other unpleasant symptoms, such as belching, excessive fullness and vomiting, he adds.

"Those are going to sit like a rock in your stomach and make you feel sick," McGowan notes.

High-fat foods tend to cause a lot of diarrhea, says Dr. Shauna Levy, a specialist in obesity medicine and medical director of the Tulane Bariatric and Weight Loss Center in New Orleans.

"I’ve seen an almost dumping syndrome-like response in people taking GLP-1s when they eat simple carbohydrates and high-fat foods," Levy tells TODAY.com.

One Ozempic patient previously told TODAY.com she could once eat a whole pizza, but after using the medication, she’d feel “completely sick” after eating two slices because it was too much grease. Another patient could no longer tolerate hoagies.

Fruits and Vegetables That Contain Significant Roughage

Roughage is the indigestible portion of food. McGowan says fruits and vegetables that contain a lot of it are also slow to exit the stomach and can be problematic. The list includes stringy raw fruits and vegetables, such as pineapple or celery, and those with a tough peel, such as an apple.

Gas-Forming Vegetables

They include broccoli, cauliflower, cabbage, Brussels sprouts, onions and asparagus can also lead to excessive, unpleasant gas, he adds.

Sweet Foods and Drinks

Patients should skip sweet foods if they experience nausea, advises Novo Nordisk, the pharmaceutical company that makes both Ozempic and Wegovy.

Sugary foods can cause stomach aches, Levy says. She also advises skipping sugary drinks.

Fizzy, carbonated drinks can play a role in nausea and indigestion, a study cautioned.

Spicy Foods

If a patient has baseline acid reflux, any foods that exacerbate the condition may be more likely to exacerbate reflux on GLP-1s because the medications delay gastric emptying and can cause acid reflux, Levy says. Spicy foods would fit into that category.

Symptoms include heartburn and regurgitation, according to the National Institute of Diabetes and Digestive and Kidney Diseases.

But if you’re somebody who doesn’t have acid reflux, spicy food is probably fine, Levy notes.

What Should You Avoid While Taking Ozempic?

Alcohol

One benefit seen with GLP-1 medications is less desire to drink alcohol, but patients still need to be careful and not overindulge, McGowan says.

Alcohol is a problem for multiple reasons, Levy cautions.

“One, it’s just empty calories. Two, it tends to make people make decisions that they otherwise might not make,” she notes.

“It could increase hunger, and the whole point of GLP-1s, or at least one of the points, is to decrease hunger. So it sort of negates their purpose.”

Alcohol is probably fine in moderation, but some people may not be able to tolerate it, Levy adds.

Caffeine

Limiting or avoiding caffeine is recommended during weight loss because of the potential diuretic effect of high caffeine intake, the Obesity study authors note.

This can lead to dehydration, which is already a potential concern for patients who are eating less and tend to drink less on GLP-1 drugs, doctors say.

Nausea-Inducing Foods and Habits

Overall, figuring out which foods and drinks can cause problems is a trial-and-error process, Levy says.

Registered dietitian Emily Rubin, who works at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, also offered these tips to reduce nausea while on the medication:

- Don’t eat or cook strong-smelling food.

- Don’t eat too quickly and don’t have a large drink with meals.

- Don’t lie down soon after eating.

- Don’t wear tight clothes around your waist.

What Is Safe to Eat on Ozempic?

Class (B2B/B2C)
B2C
Ingest Status
Error
Dedupe hash
4ea432261b1142dea6ec497b7e6eccfa
Press Eligible
No
Press Eligible Reason
Drupal Push 422
Source Name
Truveta
Image URL
https://media-cldnry.s-nbcnews.com/image/upload/t_social_share_1200x630_center,f_auto,q_auto:best/rockcms/2023-08/ozempic-foods-to-avoid-zz-230823-def008.jpg
Source Node
Content Hash (SHA-256, erste 32 hex)
ea51252761fec81e4961b90cc2e10843
People With Type 2 Diabetes Lost up to 60 Pounds on Lilly’s Latest Weight Loss Drug
Image File
Original HTML

Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published Tuesday in The Lancet.

It’s the most weight loss ever recorded in a drug trial for diabetes patients, a group that often has a harder time losing weight.

In clinical trials for semaglutide and tirzepatide, people with Type 2 diabetes lost up to 10% (21 pounds) and 15% (34 pounds) of their body weight, respectively. (Those are not direct comparisons, as the drugs were not evaluated in head-to-head clinical trials.)

Retatrutide “is truly an advance in diabetes care,” said Dr. Susan Spratt, an endocrinologist and the senior medical director for the Population Health Management Office at Duke Health in North Carolina. She was not involved in the trial and does not receive money from Eli Lilly. “It rivals gastric bypass surgery without the surgery.”

Spratt said many diabetes medications, such as insulin, cause weight gain.

“It can be discouraging to manage your diabetes well but gain weight,” she said.

Lilly’s trial included more than 1,110 patients who had an average starting weight of about 234 pounds and an average body mass index, or BMI, of about 38. People were randomly assigned to take one of three weekly doses of retatrutide or a placebo for 80 weeks. By the end of the trial, more than half of participants’ BMI fell below 30, the cutoff for obesity.

Results from another trial, published Tuesday in the New England Journal of Medicine, found retatrutide helped patients without Type 2 diabetes who have obesity or are overweight lose up to 70 pounds, or 25% of their body weight on average, after 80 weeks. That data included a subset of patients with severe obesity, who lost up to 85 pounds, or 30% of their body weight, after 104 weeks — the most weight loss ever recorded in a medication trial and on par with bariatric surgery.

Like semaglutide and tirzepatide, retatrutide works by mimicking a hormone called GLP-1. What sets retatrutide apart is its classification as a “triple agonist.” Lilly’s tirzepatide, a “double agonist,” mimics two hormones (GLP-1 and GIP), and retatrutide targets three by adding a hormone called glucagon.

Lilly hasn’t submitted retatrutide for approval to the Food and Drug Administration, but its clinical trial results have already cemented it as one of the drug industry’s most highly anticipated treatments. Lilly says it plans to file for approval early next year.

Unauthorized, copycat versions of retatrutide are already being made and sold through wellness platforms, med spas and compounding pharmacies. The drug is often labeled as “for research use only,” a legal workaround to sell compounds they claim aren’t meant for humans. Lilly has filed lawsuits against companies selling unapproved versions of the drug.

Retatrutide’s Other Benefits

Retatrutide also helps reduce the severity of sleep apnea and lower knee arthritis pain. Earlier data suggests the drug appears to help the heart.

The new trial found that retatrutide, like other GLP-1 drugs, which were initially developed as diabetes medications, effectively lowered blood sugar levels in patients with diabetes.

Retatrutide lowered A1C levels — a measure of a person’s average blood sugar levels over the previous two to three months — by up to 1.6%, compared with 0.2% with a placebo, according to the trial results.

Up to 40% of patients in the trial reached an A1C below 5.7%, below the cutoff for diabetes and prediabetes.

“The retatrutide data is very exciting,” Dr. Michelle Ponder, an assistant professor of medicine at Duke University School of Medicine in North Carolina, wrote in an email. A 5.7% A1C level means “that their diabetes went into remission,” said Ponder, who was not involved with Lilly’s trial.

She added, however, that retatrutide “may be too strong for some patients,” particularly those with only mild diabetes or slightly elevated weight.

They “may be better suited to the medications we already have available on the market such as Ozempic or Mounjaro,” she said.

She added that whenever switching medications, there is a chance patients could experience a change in the frequency of side effects.

Side effects of retatrutide were similar to those of other GLP-1 medications, with patients most commonly reporting diarrhea, nausea, constipation and vomiting. Lilly said the side effects were mild to moderate in severity. About 8% of people in the trial taking the highest dose stopped taking the drug, compared with about 5% of people taking the placebo.

This story originally appeared on NBCNews.com.

Class (B2B/B2C)
B2C
Ingest Status
Error
Dedupe hash
32783f0bbf45ef54f5909563fca49bda
Press Eligible
No
Press Eligible Reason
Drupal Push 422
Source Name
Truveta
Image URL
https://media-cldnry.s-nbcnews.com/image/upload/t_social_share_1200x630_center,f_auto,q_auto:best/rockcms/2023-06/230623-eli-lilly-hq-al-1255-1ef366.jpg
Source Node
Content Hash (SHA-256, erste 32 hex)
26070b018e88966b0a3f5a2a087643d3
What Is Esophagitis? Kim Kardashian Diagnosed With Condition Related to Father’s Fatal Cancer
Image File
Original HTML

Kim Kardashian shares on the upcoming season of “The Kardashians” that she has been diagnosed with a condition that can lead to the type of cancer that caused her father’s death more than 20 years ago.

The reality star and beauty mogul is shown discussing her health in a trailer released on Sept. 17 for the eighth season of the Hulu reality show.

“I have something called esophagitis,” Kardashian says in the trailer.

She is then seen in a hospital bed as a voice off camera asks, “Didn’t your father? Isn’t that what he died of?” Kardashian answers, “Yes.”

“I can’t; it makes me want to cry,” Kardashian’s mother, Kris Jenner, then says.

Here’s what to know about the condition and how it’s connected to the death of Robert Kardashian.

What Is Esophagitis?

It’s a condition in which your esophagus, the organ connecting the mouth to the stomach, is inflamed, according to the Cleveland Clinic.

Esophagitis can cause chest pain or make swallowing difficult by creating the sensation that your throat is burning, swollen or sore.

It’s usually treatable, but if it’s severe and goes untreated, it can cause ulcers in the esophagus’ lining, scarring that can lead to difficulty swallowing, and a change in your esophageal tissues that can lead to esophageal cancer.

What Causes Esophagitis?

A common cause of the condition is chronic acid reflux, where acids in your stomach reflux into your esophagus, per the Cleveland Clinic. Frequent acid reflux or vomiting can cause esophagitis.

Causes of esophagitis include:

- Acid reflux

- Medications

- Infections

- Allergies

- Radiation

- Autoimmune disease

Frequently using certain medications like chemotherapy drugs, antibiotics and acetaminophen can also cause esophagitis by eroding the mucous lining of your esophagus, according to the Cleveland Clinic.

Infectious esophagitis is rare and is usually caused by fungal or viral infections or occurs in those with weakened immune systems.

Cancer patients who undergo radiation therapy targeting the esophagus, chest or throat can also develop chronic esophagitis.

What Did Robert Kardashian Die From?

Kardashian was the father of Kim, Khloé, Kourtney and Rob Kardashian and the ex-husband of Kris Jenner. He was an attorney and businessman best known for being part of the defense team in the O.J. Simpson trial in 1995.

He died at 59 years old of esophageal cancer in 2003, which Kardashian references in the trailer.

Chemotherapy or radiation treatments for esophageal cancer can cause esophagitis. Conversely, untreated esophagitis can potentially lead to a diagnosis of esophageal cancer, per Cleveland Clinic.

In a 2023 interview with GQ magazine, Kim Kardashian recalled a conversation with her father that she had near the end of his life.

“I know you’re going to be okay,” she remembered her father telling her. “It’s almost like I can see ahead. I know you’re going to be okay, but just take care of your siblings for me. Just make sure you take care of them.”

Khloé Kardashian, 42, who was 19 when her father died, spoke about his loss with grief expert David Kessler during a 2025 episode of her “Khloé in Wonder Land” podcast.

“My dad died really quickly,” she said. “He had esophageal cancer, and I think he died like six or seven weeks after diagnosis of his cancer, so it was really fast. And my dad, I don’t think was lying to us; I don’t think he could accept himself that it was terminal, but he never used those words with us.”

Class (B2B/B2C)
B2C
Ingest Status
Error
Dedupe hash
061a1897ea2571eb81a81c16661d619a
Press Eligible
No
Press Eligible Reason
Drupal Push 422
Source Name
Truveta
Image URL
https://media-cldnry.s-nbcnews.com/image/upload/t_social_share_1200x630_center,f_auto,q_auto:best/rockcms/2026-09/kim-kardashian-esophagitis-as09182026-85b607.jpg
Source Node
Content Hash (SHA-256, erste 32 hex)
ce7702c98cf664e7118adf2d2986a964
Could the Suspected Pneumonic Plague Case in Russia Lead to an Outbreak? Experts Weigh in
Image File
Original HTML

News of the death of a laboratory worker at a research facility in Russia from suspected pneumonic plague has swept the world, sparking concern about the risk of an outbreak, or even a pandemic.

The medieval-sounding disease still causes a handful of cases around the world every year — yes, the plague never went away — and it’s fully treatable with antibiotics.

However, the lack of details available around the scientist’s death and the intense public health response from Russian authorities has some experts on high alert.

The 28-year-old woman, who worked as a lab technician at the Irkutsk Anti-Plague Institute of Siberia and the Far East, died last week of “pneumonia of undetermined” origin, NBC News reported, citing a Russian official.

As of Oct. 8, the cause of the staffer’s fatal pneumonia has not been confirmed by Russian authorities.

However, the U.S. State Department and the Centers for Disease Control and Prevention have both said that they are monitoring reports of a “suspected case of pneumonic plague” in Irkutsk.

Pneumonic plague is a severe and often fatal lung infection caused by yersinia pestis, the same bacteria that causes the bubonic plague. It can spread from person to person through the inhalation of respiratory droplets.

Initial media reports suggested the staffer was infected after an accidental lab exposure, World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus said in a media briefing on Wednesday.

According to the Irkutsk regional governor, Igor Kobsev, no “microorganisms linked to the employee’s professional activities were detected” in her body, NBC News reported.

However, the death has prompted at least one hospital, where she was treated, to enter quarantine, and nearly 200 people with whom she had contact are under medical observation, NBC News reported, citing a local official and Russian media.

Russia’s consumer and health watchdog, Rospotrebnadzor, also said in a statement that “no other infectious disease pathogens were detected among the contacts,” NBC News reported. The agency later confirmed that testing had identified two cases of COVID-19 and two cases of rhinovirus.

No cases of plague have been reported in the city of Irkutsk so far, the WHO said, quoting a response from the Russian government.

According to Russian authorities, the “sanitary-epidemiological situation” in the Irkutsk region is “stable,” NBC News reported.

There are still many questions about the scientist’s death, experts tell TODAY.com. The WHO is calling for increased transparency, and the State Department is encouraging Russia to “share accurate information quickly and openly,” a spokesperson said.

As the situation unfolds, rumors are circulating rapidly on social media, with many fearing another COVID-level pandemic. Here’s what experts think, and why plague may be not be as concerning.

Pneumonic Plague Unlikely to Cause a Pandemic

“The plague cannot cause widespread outbreaks the way it once did because we have antibiotics,” Dr. Amesh Adalja, a senior scholar at the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health, tells TODAY.com.

The suspected pneumonic plague case in Russia poses a “very low risk” outside of the country, the WHO said.

“At this time, there is no indication of a broader threat to the United States, but CDC and our interagency partners are prepared and will continue to monitor the situation closely,” the CDC said in a statement posted to X on Tuesday.

“Yes, the plague killed one-third of Europe’s population during the Middle Ages, but they didn’t even know what caused it,” says Adalja.

Bubonic vs. Pneumonic Plague

All three types of plague are caused by the same bacteria, yersinia pestis, but affect different parts of the body.

Bubonic plague, the most common type, occurs when yersinia pestis infects the lymph nodes, says Adalja. It spreads to people through the bite of a flea carrying the bacteria or contact with infected animals, per the CDC. Septicemic plague is caused by the bacteria entering the bloodstream directly.

Pneumonic plague, the rarest type, occurs when yersinia pestis infects the lungs. It’s spread by inhaling respiratory droplets from an infected person, but it can also develop if untreated bubonic or septicemic plague spreads to the lungs, Adalja notes.

It’s the most virulent type of plague, per the WHO. “But it’s easily containable,” Adalja says.

How Pneumonic Plague Spreads and Treatment

Although pneumonic plague can transmit through airborne secretions, it doesn’t spread easily in this way.

“It’s not a very efficient mode of transmission. Plague isn’t something that spreads in the manner of a virus. It’s nowhere near as contagious as COVID or influenza,” says Adalja.

“It’s difficult to get unless you are in prolonged, direct, close contact with a sufferer,” Dr. Susan Jones, a veterinarian and professor at the University of Minnesota who has investigated plague in Russia, tells TODAY.com.

Antibiotics are also highly effective at treating and preventing plague after a person is exposed.

“Let’s say it is pneumonic plague. This woman worked at an anti-plague institute. They have post-exposure prophylaxis protocols, antibiotics,” Adalja explains.

Ongoing Quarantines in Russia

According to Russian media reports, quarantines are in effect at the Siberian hospital where the lab worker died, and 60% of her contacts have been tested so far, NBC News reported.

It’s unlikely that potentially exposed contacts would’ve left Irkutsk on flights before being quarantined, Jones adds. Additionally, travel to and from Russia to the U.S. is very limited.

Dr. Ashish Jha, the White House’s former COVID response coordinator, told NBC News that if this is an isolated case of pneumonic plague, “it will probably end there.”

“Thousands of cases of pneumonic plague occur all over the world every year,” Adalja adds. Rarely do these cause outbreaks.

“This is not the Black Death, and this is not COVID,” says Jones.

Public Health Experts Are Still Concerned

Not all experts are convinced pneumonic plague is to blame for the lab worker’s death.

“I don’t even know where ‘plague’ came from, other than that it’s on the door of the building where she worked,” says Adalja.

Lisa Morici, Ph.D., an immunologist at the Tulane University School of Medicine, told NBC News that “maybe it’s going to come out that she died from something unrelated and it was just a coincidence” that she was a technician at an anti-plague lab.

It’s unclear if the deceased worker handled other pathogens. “It could be something else that’s more scary than plague,” says Adalja.

The WHO has requested additional information to clarify the cause of the fatal pneumonia case and “media reports of a second employee with pneumonia of undetermined cause,” the health agency’s chief said in a post on X.

The Russian government’s response to a potential isolated plague case also raises suspicion among some experts.

“When you see contacts being monitored, hospitals being quarantined, the head of their public health agency flying there, that’s not congruent with the response for something as easy to handle as plague,” says Adalja.

“What exactly was going on inside that lab that has led to the security services of Russia getting involved?” Jha told NBC News.

However, Jones, who has visited anti-plague institutes in Russia, says the aggressive public health response is “normal” and follows protocol that dates back to Soviet times. “There (also) aren’t enough public health personnel to escort 200 people into quarantine, so security services are involved,” Jones explains.

Symptoms of Pneumonic Plague

After inhaling respiratory droplets from a person infected with pneumonic plague, it can take as little as 24 hours to develop symptoms, according to the CDC.

The early signs of pneumonic plague include:

- Fever

- Chills

- Weakness

- Headache

These can rapidly develop into pneumonia, leading to:

- Shortness of breath

- Coughing

- Chest pain

- Bloody mucus

- Respiratory distress

If left untreated, pneumonic plague is usually 100% fatal, per the WHO.

The infection can be treated with antibiotics, but these are most effective when given early, within 24 hours of symptom onset, Jones adds.

Pneumonic Plague in the US

In the U.S., an average of seven cases of plague are reported every year, per the CDC. About 80% of these are bubonic plague.

The disease has been in the U.S. since the early 1900s, when infected rats entered the country from ships, says Adalja.

The last urban plague epidemic occurred from 1924-1925 in Los Angeles, per the CDC. Since then, the bacteria has spread to wild rodents, and most cases are scattered in rural areas.

It’s now endemic to the Western U.S., and most cases are reported in Arizona or New Mexico, says Adalja.

In 2025, a man in Arizona died of pneumonic plague after being exposed while working with infected cats, per the CDC.

Overall, this type of plague is very rare — and unlike when the novel coronavirus emerged, scientists have the tools to fight it.

“People are talking about plague as if it’s the 14th century and not the 21st century,” says Adalja.

In the meantime, experts are calling for increased transparency and communication from Russia.

Class (B2B/B2C)
B2C
Ingest Status
Need Review
Dedupe hash
bf6e9ef3feab229b0be4fc74e191fd30
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): The target contains a factual mismatch in a medical claim: it says symptoms can start 'within 24 hours' of exposure, but the source says it can take 'as little as 24 hours' to develop symptoms (i.e., at least 24 hours). This is not a faithful paraphrase.
Source Name
Truveta
Image URL
https://media-cldnry.s-nbcnews.com/image/upload/t_social_share_1200x630_center,f_auto,q_auto:best/rockcms/2026-10/plague-russia-future-outbreaks-mh-10072026-ae86de.jpg
Source Node
Generated Article_json
{"target_audience": "b2c", "is_medical": true, "ai_generated_title": "Suspected Plague Death in Siberia: What Experts Say You Should Know", "body_html": "<p><strong>Irkutsk -- [CURRENT_DATE] --</strong> The World Health Organization rates the risk outside Russia as \"very low\" after a lab technician's death from suspected pneumonic plague, and the disease can be treated with antibiotics.</p><p>The 28-year-old woman worked at the Irkutsk Anti-Plague Institute of Siberia and the Far East. She died last week of pneumonia of undetermined origin, according to a Russian official cited by NBC News. As of Oct. 8, Russian authorities have not confirmed the cause. The U.S. State Department and the CDC say they are monitoring reports of a suspected case.</p><h5>Nearly 200 contacts are under medical observation</h5><p>The hospital where she was treated has entered quarantine. Nearly 200 people who had contact with her are being observed, and about 60% had been tested at last report. Russia's health watchdog, Rospotrebnadzor, said testing found two COVID-19 cases and two rhinovirus cases among contacts, but no other infectious pathogens. The WHO says no plague cases have been reported in the city of Irkutsk.</p><p>Regional governor Igor Kobsev said no microorganisms linked to the employee's professional activities were detected in her body. The WHO has asked Russia for more information, including on media reports of a second employee with pneumonia of undetermined cause.</p><h5>Experts say plague spreads far less easily than COVID</h5><p>Dr. Amesh Adalja of the Johns Hopkins Center for Health Security says antibiotics keep plague from causing widespread outbreaks. He says pneumonic plague is a poor spreader compared with COVID or influenza. Dr. Susan Jones of the University of Minnesota, who has investigated plague in Russia, says it is hard to catch without prolonged, close contact with a patient. \"This is not the Black Death, and this is not COVID,\" she says.</p><p>Not everyone is convinced plague is the cause. Adalja notes the worker may have handled other pathogens, and says the cause \"could be something else that's more scary than plague.\" Tulane immunologist Lisa Morici raised the possibility that the death was unrelated to her workplace.</p><p>Adalja also questions the scale of Russia's response. Jones says it is normal and follows protocols dating to Soviet times, with security services involved because there are too few public health staff to escort 200 people into quarantine.</p><h5>Symptoms can appear within 24 hours of exposure</h5><p>According to the CDC, symptoms can start within 24 hours of inhaling infected droplets. Early signs are fever, chills, weakness and headache. They can quickly progress to shortness of breath, coughing, chest pain, bloody mucus and respiratory distress. Untreated, pneumonic plague is usually fatal, the WHO says. Antibiotics work best within 24 hours of symptom onset.</p><h5>The U.S. averages seven plague cases a year</h5><p>About 80% of U.S. cases are bubonic, and most occur in rural areas of the West, mainly Arizona and New Mexico. A man in Arizona died of pneumonic plague in 2025 after exposure to infected cats, per the CDC. The CDC says there is no indication of a broader threat to the United States.</p>", "meta_description": "A lab worker's suspected pneumonic plague death in Siberia alarmed the internet, but the WHO sees very low outside risk and antibiotics treat the disease.", "seo_keywords": "pneumonic plague, Irkutsk, Russia lab worker death, WHO, CDC, yersinia pestis, plague symptoms, antibiotics, quarantine", "companies": [], "topics": ["Public Health", "Health, Wellness & Beauty"], "markets": ["Global", "United States"], "locations": ["Irkutsk", "Siberia", "Arizona"], "products": [], "cta_text": "Follow WHO and CDC updates on the suspected plague case in Irkutsk", "learn_more": "", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}
Content Hash (SHA-256, erste 32 hex)
cf212a8c4e048997a1197addc9e150a9
Presley Gerber Shared Mental Health, Addiction Struggles Before Death: ‘I’ve Had a Lot of Time to Look Into Myself’
Image File
Original HTML

Presley Gerber was open about his struggles with mental health and substance use before his death at 27.

The son of model Cindy Crawford and businessman Rande Gerber passed away Sunday.

“The family is asking for privacy during this very difficult and painful time,” a statement on behalf of his family noted.

Gerber, who began modeling as a teen, once called dealing with mental health issues a “24/7 job” and posted candid videos he called “Mental Health Mondays” on his Instagram page.

How Did Presley Gerber Die? What We Know

Gerber died at a “rehab facility,” according to the Los Angeles County Medical Examiner.

No cause of death was given, but an exam of his body has been scheduled, the website entry notes.

Police responded to a report of a possible overdose at about 9:35 a.m. on Sunday, Sept. 20, and found “an adult male who was deceased,” the Santa Monica Police Department said in a statement.

Detectives are investigating the death “as a suspected overdose. At this time, there is no indication of foul play,” the statement noted.

A law enforcement source told NBC News that he was found unresponsive at the rehab facility in Los Angeles on Sunday morning. He had checked into the facility at 10 p.m. the night before. The sourced added that he had likely been dead for some time when he was found in the room where he was sleeping.

He Spoke About Mental Health at an Event a Few Months Before His Death

In June, Gerber appeared with his parents at an event in Malibu, California, where he took part in a “candid panel discussion about mental health,” People magazine reported. It was his last public appearance.

“The most free I felt was when I was finally honest with myself,” he told the audience.

The model also offered advice about boosting mental health: “Move your body regardless of how you’re feeling. Get outside. Get some sun,” he said. “If you don’t feel like moving, lay on the grass.”

In December 2025, Presley spoke about his struggles in a since-deleted video on Instagram, revealing he’d largely given up drinking in recent years, noting that alcohol was “no longer serving” him, E! News reported.

He said he was taking various medications including Valium — the brand name for diazepam, which is used to relieve anxiety and control agitation caused by alcohol withdrawal — and buprenorphine, a medication to treat opioid use disorder, according to E! News.

He added he was also taking Xanax, the brand name for alprazolam, which is used to treat anxiety and panic disorders, for “when the panic attacks are really, really bad,” but was seeking more direction about his dosages.

“Every psychiatrist I’ve had — and I’ve had, like, 15 — they’re all like, ‘Here’s 20 medications,’” Gerber said. “‘Take this if you feel like this, take this as needed.’ And I’m like, ‘No, don’t give me that much leeway. I need some direction.’”

He Was a Mental Health Advocate

In a 2023 podcast, he said he struggled with mental health and depression, and wanted to help others dealing with similar issues.

“Whether I help one person or a 100 people get out of that place that I was in at one point in my life, that’s all I need to do,” Gerber said.

“I’ve had a lot of time to look into myself and learn about myself with therapists.”

Mental health is “such a big part of my life,” he added, calling his focus on it a “24/7 job” and noting “there’s no judgement.”

“I’ve seen a lot of stuff and I’ve learned a lot of things, and what I hope I can do is have made the mistakes for some other people so they don’t have to make the same mistakes that I made,” he said.

He Tried Ibogaine

In a video he posted on Instagram in March, Gerber was seen in Cancun, Mexico, taking part in what he describes as a “Pre Ibogaine Flood Dose — quiet moment before everything changed.”

“I was absolutely terrified,” he writes in the caption. “Letting go of control didn’t come easy, but I trusted there was something bigger than me guiding it. I knew why i was there. I faced what I had been running from, and somewhere in all of it, i started finding my way back to myself.”

Ibogaine, a psychoactive compound found in the root of Tabernanthe iboga, a shrub native to Central Africa, has been studied for its potential in treating opioid and alcohol addiction, and other substance use disorders, according to the University of Virginia Division of Medical Toxicology.

It has hallucinogenic properties, and may prevent cravings and withdrawal.

Sister Kaia Gerber Spoke About His Addiction Struggles in a Recent Interview

After Gerber posted the candid video about his struggles in December, his younger sister, Kaia, praised his honesty and vulnerability.

“My parents for most of our lives were very, very private and didn’t share anything — and now we have this absolute teacher, my brother, who says, ‘I’m gonna be very human for everyone.’ There’s only so much you can hide from the world. And trying to put a lid on something just makes the person feel like you’re ashamed of them,” she told Vogue.

The outlet noted that he had a “decade-long struggle with drug addiction.”

If you or someone you know is struggling or in emotional distress, call or text 988 or chat at 988lifeline.org 24/7 to reach the 988 Suicide & Crisis Lifeline. For additional resources, visit SpeakingOfSuicide.com/resources.

Ingest Status
Rejected
Dedupe hash
e6c8a76cd82cd809271aa720ce33559f
Press Eligible Reason
JSON nicht lesbar - manuelle Pruefung noetig: Inhalt konnte nicht als JSON geparst werden
Source Name
Truveta
Image URL
https://media-cldnry.s-nbcnews.com/image/upload/t_social_share_1200x630_center,f_auto,q_auto:best/rockcms/2026-09/presley-gerber-addiction-mental-health-death-mh-09212026-a6bda1.jpg
Source Node
Content Hash (SHA-256, erste 32 hex)
800dd3f455ff2c99bdb14c319ecaa405